Epidemiology and risk factors of venous thromboembolism

Seminars in Thrombosis and Hemostasis

Volumn 32, Issue 7, 2006, Pages 651-658

  Ageno, Walter ^a,d   Squizzato, Alessandro ^a   Garcia, David ^b   Imberti, Davide ^c  

^a UNIVERSITY OF INSUBRIA   (Italy)

^b UNIVERSITY OF NEW MEXICO   (United States)

^c AUSL di Piacenza   (Italy)

^d OSPEDALE DI CIRCOLO   (Italy)

Author keywords

Epidemiology; Prophylaxis; Risk factors; Venous thromboembolism

Indexed keywords

ANTICOAGULANT AGENT; GESTAGEN; ORAL CONTRACEPTIVE AGENT;

ACUTE RESPIRATORY FAILURE; AGE; ANTICOAGULATION; CANCER; DECISION MAKING; EPIDEMIC; HEART FAILURE; HOSPITAL PATIENT; HUMAN; INCIDENCE; MORTALITY; OBESITY; PREVALENCE; PRIORITY JOURNAL; RECURRENCE RISK; REVIEW; RISK FACTOR; THROMBOPHILIA; VENOUS THROMBOEMBOLISM;

CONTRACEPTIVES, ORAL; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; MALE; NEOPLASMS; OBESITY; POSTOPERATIVE COMPLICATIONS; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; RECURRENCE; RISK FACTORS; THROMBOEMBOLISM; THROMBOPHILIA; VENOUS THROMBOSIS;

EID: 33750329433     PISSN: 00946176     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-951293     Document Type: Review

References (76)

1. Turkstra F, Kuijer PMM, van Beek EJR, et al. Diagnostic utility of ultrasonography of leg veins in patients suspected of having pulmonary embolism. Ann Intern Med 1997;126:775-781
2. Meignan M, Rosso J, Gauthier H, et al. Systematic lung scans reveal a high frequency of silent pulmonary embolism in patients with proximal deep venous thrombosis. Arch Intern Med 2000;160:159-164
3. Kyrle PA, Eichinger S. Deep vein thrombosis. Lancet 2005; 365:1163-1174
4. White RH. The epidemiology of venous thromboembolism. Circulation 2003;107(23 Suppl 1):I4-8
5. Anderson FA Jr, Wheeler HB, Goldberg RJ, et al. A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism: the Worcester DVT Study. Arch Intern Med 1991;151:933-938
6. Silverstein MD, Heit JA, Mohr DN, Petterson TM, O'Fallon WM, Melton J III. Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med 1998;158:585-593
7. Nordstrom M, Lindblad B, Bergqvist D, Kjellstrom T. A prospective study of the incidence of deep-vein thrombosis within a defined urban population. J Intern Med 1992;232:155-160
8. Oger E. Incidence of venous thromboembolism: a community-based study in western France. Thromb Haemost 2000;83:657-660
9. Kyrle PA, Minar E, Bialonczyk C, Hirschl M, Weltermann A, Eichinger S. The risk of recurrent venous thromboembolism in men and women. N Engl J Med 2004;350:2558-2563
10. Christiansen SC, Cannegieter SC, Koster T, Vandenbroucke JP, Rosendaal FR. Thrombophilia, clinical factors, and recurrent venous thrombotic events. JAMA 2005;293:2352-2361
11. White RH, Zhou H, Romano PS. Incidence of idiopathic deep venous thrombosis and secondary thromboembolism among ethnic groups in California. Ann Intern Med 1998;128:737-740
12. Ridker PM, Miletich JP, Hennekens CH, et al. Ethnic distribution of factor V Leiden in 4047 men and women. Implications for venous thromboembolism screening. JAMA 1997;277:1305-1307
13. Herrmann FH, Koesling M, Schroder W, et al. Prevalence of factor V Leiden mutation in various populations. Genet Epidemiol 1997;14:403-411
14. Bounameaux H, Hicklin L, Desmarais S. Seasonal variation in deep vein thrombosis. BMJ 1996;312:284-285
15. Wroblewski BM, Siney P, White R. Seasonal variation in fatal pulmonary embolism after hip arthroplasty. Lancet 1990;335:56
16. Prandoni P, Lensing AWA, Cogo A, et al. The long-term clinical course of acute deep venous thrombosis. Ann Intern Med 1996;125:1-7
17. Heit JA, Mohr DN, Silverstein MD, Petterson TM, O'Fallon WM, Melton LJ III. Predictors of recurrence after deep vein thrombosis and pulmonary embolism. Arch Intern Med 2000;160:761-768
18. Heit JA, Silverstein MD, Mohr DN, Petterson TM, O'Fallon WM, Melton LJ III. Predictors of survival after deep vein thrombosis and pulmonary embolism: a population-based, cohort study. Arch Intern Med 1999;159:445-453
19. Goldhaber SZ, Visani L, De Rosa M. for ICOPER. Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet 1999;353:1386-1389
20. Virchow R. Gesammelte Abhandlungen zur wissenschaftlichen Medizin. Frankfurt, Germany: Medinger Sohn; 1856:219-732
21. Rosendaal FR. Venous thrombosis: a multicausal disease. Lancet 1999;353:1167-1173
22. Hansson PO, Welin L, Tibblin G, Eriksson H. Deep vein thrombosis and pulmonary embolism in the general population. The Study of Men Born in 1913. Arch Intern Med 1997;157:1665-1670
23. Goldhaber SZ, Grodstein F, Stampfer MJ, et al. A prospective study of risk factors for pulmonary embolism in women. JAMA 1997;277:642-645
24. Tsai AW, Cushman M, Rosamond WD, Heckbert SR, Polak JF, Folsom AR. Cardiovascular risk factors and venous thromboembolism incidence. Arch Intern Med 2002;162:1182-1189
25. Abdollahi M, Cushman M, Rosendaal FR. Obesity: risk of venous thrombosis and the interaction with coagulation factor levels and oral contraceptive use. Thromb Haemost 2003;89:493-498
26. Hansson PO, Eriksson H, Welin L, Svardsudd K, Wilhelmsen L. Smoking and abdominal obesity. Risk factors for venous thromboembolism among middle-aged men: The Study of Men Born in 1913. Arch Intern Med 1999;159:1886-1890
27. Mateo J, Oliver A, Borrell M, Sala N, Fontcuberta J. Laboratory evaluation and clinical characteristics of 2,132 consecutive unselected patients with venous thromboembolism-results of the Spanish Multicentric Study on Thrombophilia. Thromb Haemost 1997;77:444-451
28. Wells PS, Blajchman MA, Henderson P, et al. Prevalence of antithrombin deficiency in healthy blood donors: a cross sectional study. Am J Hematol 1994;45:321-324
29. Tait RC, Walker ID, Perry DJ, et al. Prevalence of antithrombin deficiency in the healthy population. Br J Haematol 1994;87:106-112
30. Martinelli I, Mannucci PM, De Stefano V, et al. Different risks of thrombosis in four coagulation defects associated with inherited thrombophilia: a study of 150 families. Blood 1998;92:2353-2358
31. Tait RC, Walker ID, Reitsma PH, et al. Prevalence of protein C deficiency in the healthy population. Thromb Haemost 1995;73:87-93
32. Ben-Tal O, Zivclin A, Selighson U. The relative frequency of hereditary thrombotic disorders among 107 patients with thrombophilia in Israel. Thromb Haemost 1989;61:50-54
33. Crowther MA, Kelton JG. Congenital thrombophilic states associated with venous thrombosis: a qualitative overview and proposed classification system. Ann Intern Med 2003;138:128-134
34. Koster T, Rosendaal FR, de Ronde H, Briet E, Vandenbroucke JP, Bertina RM. Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study. Lancet 1993;342:1503-1506
35. Salomon O, Steinberg DM, Zivelin A, et al. Single and combined prothrombotic factors in patients with idiopathic venous thromboembolism: prevalence and risk assessment. Arterioscler Thromb Vasc Biol 1999;19:511-518
36. Ridker PM, Goldhaber SZ, Danielson E, et al. for the PREVENT Investigators. Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism. N Engl J Med 2003;348:1425-1433
37. Poort SR, Rosendaal ER, Reitsma PH, Bertina RM. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996;88:3698-3703
38. Rosendaal FR, Doggen CJ, Zivelin A, et al. Geographic distribution of the 20210 G to A prothrombin variant. Thromb Haemost 1998;79:706-708
39. Goyette P, Frosst P, Rosenblatt DS, Rozen R. Seven novel mutations in the methylenetetrahydrofolate reductase gene and genotype/phenotype correlations in severe methylenetetrahydrofolate reductase deficiency. Am J Hum Genet 1995;56:1052-1059
40. Mudd SH, Skovby F, Levy HL, et al. The natural history of homocystinuria due to cystathionine beta-synthase deficiency. Am J Hum Genet 1985;37:1-31
41. Kluijtmans LA, van den Heuvel LP, Boers GH, et al. Molecular genetic analysis in mild hyperhomocysteinemia: a common mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for cardiovascular disease. Am J Hum Genet 1996;58:35-41
42. Levine JS, Branch DW, Rauch J. The antiphospholipid syndrome. N Engl J Med 2002;346:752-763
43. Samama MM. An epidemiologic study of risk factors for deep vein thrombosis in medical outpatients. The Sirius Study. Arch Intern Med 2000;160:3415-3420
44. Schulman S, Granqvist S, Holmström M, et al. The duration of oral anticoagulant therapy after a second episode of venous thromboembolism. N Engl J Med 1997;336:393-398
45. Schulman S, Lockner D, Juhlin-Dannfelt A. The duration of oral anticoagulation after deep vein thrombosis. A randomized study. Acta Med Scand 1985;217:547-552
46. Geerts WH, Pineo GP, Heit JA, et al. Prevention of venous thromboembolism: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126(suppl 3):338S-400S
47. Dahl OE, Gudmundsen TE, Haukeland L. Late occurring clinical deep vein thrombosis in joint-operated patients. Acta Orthop Scand 2000;71:47-50
48. Demers C, Marcoux S, Ginsberg JS, et al. Incidence of venographically proved deep vein thrombosis after knee arthroscopy. Arch Intern Med 1998;158:47-50
49. Delis KT, Hunt N, Strachan RK, et al. Incidence, natural history and risk factors of deep vein thrombosis in elective knee arthroscopy. Thromb Haemost 2001;86:817-821
50. Stringer MD, Steadman CA, Hedges AR, et al. Deep vein thrombosis after elective knee surgery: an incidence study in 312 patients. J Bone Joint Surg Br 1989;71:492-497
51. Jorgensen JO, Lalak NJ, North E, Hanel K, Hunt DR, Morris DE. Venous stasis during laparoscopic cholecystectomy. Surg Laparosc Endosc 1994;4:128-133
52. Sobolewski AP, Deshmukli RM, Brunson BE, et al. Venous hemodynamic changes during laparoscopic cholceystectomy. J Laparoendosc Surg 1995;5:363-369
53. Nguyen NT, Owings JT, Gosselin R, et al. Systemic coagulation and fibrinolysis after laparoscopic and open gastric bypass. Arch Surg 2001;136:909-916
54. Rahr HB, Fabrin K, Larsen JE, Thorlacius-Ussing O. Coagulation and fibrinolysis during laparoscopic cholecystectomy. Thromb Res 1999;93:121-127
55. Sandler DA, Martin JF. Autopsy proven pulmonary embolism in hospital patients: are we detecting enough deep vein thrombosis? J R Soc Med 1989;82:203-205
56. Goldhaber SZ, Savage DD, Garrison RJ, et al. Risk factors for pulmonary embolism: the Framingham study. Am J Med 1983;74:1023-1028
57. Lindblad B, Sternby NH, Bergqvist D. Incidence of venous thromboembolism verified by necropsy over 30 years. BMJ 1991;302:709-711
58. Baglin TP, White K, Charles A. Fatal pulmonary embolism in hospitalised medical patients. J Clin Pathol 1997;50:609-610
59. Bouthier J. The venous thrombotic risk in nonsurgical patients. Drugs 1996;52(suppl):16-29
60. Goldhaber SZ, Dunn K, MaeDougall RC. New onset of venous thromboembolism among hospitalized patients at Brigham and Women's Hospital is caused more often by prophylaxis failure than by withholding treatment. Chest 2000;118:1680-1684
61. Blom JW, Doggen CJ, Osanto S, Rosendaal FR. Malignancies, prothrombotie mutations, and the risk of venous thrombosis. JAMA 2005;293:715-722
62. Otten HM, Prins MH. Venous thromboembolism and occult malignancy. Thromb Res 2001;102:V187-V194
63. Sorensen HT, Mellemkjaer L, Olsen JH, Baron JA. Prognosis of cancers associated with venous thromboembolism. N Engl J Med 2000;343:1846-1850
64. Otten HM, Mathijssen J, ten Cate H, et al. Symptomatic venous thromboembolism in cancer patients treated with chemotherapy. An underestimated phenomenon. Arch Intern Med 2004;164:190-194
65. Macklon NS, Greer IA. Venous thromboembolic disease in obstetrics and gynaecology: the Scottish experience. Scott Med J 1996;41:83-86
66. Athrash HK, Koonin EM, Lawson HW, Franks AE, Smith JC. Maternal morbidity in the United States 1979-1986. Obstet Gynecol 1990;76:1055-1060
67. Hogberg U, Innala E, Sandstrom A. Maternal mortality in Sweden. Obstet Gynecol 1995;84:240-244
68. James K, Lohr J, Deshmukh R. Venous thrombotic complications of pregnancy. Cardiovasc Surg 1996;4:777-782
69. Rutherford S, Montoro M, McGehee W, Strong T. Thromboembolic disease associated with pregnancy: an 11 year review. Am J Obstet Gynecol 1991;164:286 (abst)
70. Eldor A. The use of low molecular weight heparin for the management of venous thromboembolism in pregnancy. Eur J Obstet Gynecol Reprod Biol 2002;104:3-13
71. Bazzan M, Donvito V. Low molecular weight heparin during pregnancy. Thromb Res 2001;101:V175-V186
72. Rosendaal FR, Van Hylckama Vlieg A, Tanis BC, Helmerhorst FM. Estrogens, progestogens and thrombosis. J Thromb Haemost 2003;1:1371-1380
73. Nelson HD, Humphrey LL, Nygren P, Teutsch SM, Allan JD. Postmenopausal hormone replacement therapy: scientific review. JAMA 2002;288:872-881
74. Samama MM, Dahl OE, Mismetti P, et al. Individualizing the risk of venous thromboembolism in medical and surgical patients: development of the decision matrix for VTE prophylaxis. J Thromb Haemost 2003;1(suppl 1):OC436 (abst)
75. Samama MM, Dahl OE, Quinlan DJ, Mismetti P, Rosencher N. Quantification of risk factors for venous thromboembolism: a preliminary study for the development of a risk assessment tool. Haematologica 2003;88:1410-1421
76. Cohen AT, Alikhan R, Arcelus J, et al. A risk assessment model for identifying medical patients who should receive thombopropylaxis. J Thromb Haemost 2003;1(suppl 1): OC437 (abst)